Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Virginia Center for Reproductive Medicine
FDA Inspection
•Virginia Center for Reproductive Medicine•February 25, 2019

Virginia Center for Reproductive Medicine – FDA Inspection, Feb 25, 2019

Record Details

This FDA Inspection record concerns Virginia Center for Reproductive Medicine, with an inspection on February 25, 2019, issued by the Center for Biologics Evaluation and Research, covering biologics.

Company
Virginia Center for Reproductive Medicine
Inspection Date
February 25, 2019
Product Type
Biologics
Office
Center for Biologics Evaluation and Research
Person
  • Shavon L. Square (Company Rep)
View Company Profile

ID · cc9cfaad-8809-4dd9-b8d4-50eaa2ccb5cf

Inspection Facts

Official Action Indicated (OAI)

Significant objectionable conditions were found and regulatory or administrative action is recommended.

Inspection number
1081380
FDA center
Biologics
Project area
Human Cellular, Tissue, and Gene Therapies
Outcome
Form 483 issued
Enforcement
Warning Letter

FDA Citations

7
  1. 21 CFR 1271.55(d)(1)(iii)Documentation--determination, by whom, date
  2. 21 CFR 1271.80(b)Specimen collections not timely
  3. 21 CFR 1271.75(d)Donors with risks not determined ineligible
  4. 21 CFR 1271.75(a)(1)Risk factors, clinical evidence
  5. 21 CFR 1271.50(a)Determination based on screening and testing
  6. 21 CFR 1271.47(a)Procedures for all other requirements
  7. 21 CFR 1271.55(b)(2)Listing and interpretation of CD tests performed

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Virginia Center for Reproductive Medicine

7
DateClassificationOfficeProject area
August 28, 2025Not classifiedBaltimore District Office
September 20, 2023VAICenter for Biologics Evaluation and ResearchBlood and Blood Products
October 29, 2021VAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
December 9, 2016Not classifiedBaltimore District Office
June 12, 2013OAICenter for Biologics Evaluation and ResearchHuman Cellular, Tissue, and Gene Therapies
View all 7 other inspections on the company page
Other documents for Virginia Center for Reproductive Medicine
  • FDA Inspection 1280934 - 2025-08-28
  • FDA Inspection 1218271 - 2023-09-20
  • FDA Inspection 1156160 - 2021-10-29
  • FDA Inspection 1000737 - 2016-12-09
  • FDA Inspection 833772 - 2013-06-12

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Virginia Center for Reproductive Medicine
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.